Developing pharmaceuticals from bench to bedside is a cumbersome and costly endeavor. Especially the clinical development but also of crucial importance in obtaining the ultimate goal of getting your product approved. Having a clear strategy for the clinical development in order to meet regulatory expectations and obtain approval of a viable indication is important.

In this webinar Dr Steffen Thirstrup, addresses why, when, and how to interact with the regulatory agencies to optimize the success of clinical development of a new medicinal product.